GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a V2-directed, RV144 vaccine-like antibody from HIV-1 infection, CAP228-16H, bound to a heterologous V2 peptide

Analyse Crystal structure of a V2-directed, RV144 vaccine-like antibody from HIV-1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FY0
Type
protein
Length
895 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Ligands
SO4

Structure

x-ray diffraction · 5 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
H—protein226——
L—protein211——
M—protein208——
I—protein216——
A, P—protein17——

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains H, P, I, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6FY0 · Crystal structure of a V2-directed, RV144 vaccine-like antibody from HIV-1 infection… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.